Security
Name: Accentia
Biopharmaceuticals and Biovest International
Case
Name: MICHAEL HILL, JAMES HILL, JOHN SCELSI, and ASM CAPITAL v. ACCENTIA
BIOPHARMACEUTICALS, INC., SAMUEL S, DUFFEY, FRANCIS E, O'DONNELL, JR., BRIAN D.
BOTTJER, CARLOS F. SANTOS, RONALD E. OSMAN, and STEVEN R, ARIKIAN,
CUSIP: 09069L102,
00430L103
ISIN: US09069L1026,
US00430L1035
Claim Filing Deadline: February 19, 2015
Exclusion Deadline: January 5, 2015
Qualification criteria:
Investors PURCHASED SHARES OF ACCENTIA BIOPHARMACEUTICALS,
INC. (ACCENTIA") OR BIOVEST INTERNATTONAL, INC. (BIOVEST") COMMON
STOCK DURING THE PERIOD JULY 26, 2008 THROUGH AUGUST 14, 2012.
Class
Action Settlement Website: www.berdonclaims.com
Class
Action Notice HERE
Proof
of Claim and Release HERE
No comments:
Post a Comment